Dexcom | DXCM - 税前利润

股票价格
61.53
每天变化
1.98 3.32%
每月一次
-1.11%
每年
-24.61%
Q2 预测
60.25


金融业
股票价格
USD
资产
USD 6.63B
现金及等价物
USD 1.12B
销售成本
USD 441.6M
流动资产
USD 4.33B
流动负债
USD 2.22B
债务
USD 1.24B
EBIT
USD 255.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.56
股本和储备
USD 2.96B
销售毛利
USD 750.3M
债务利息支出
USD 4.2M
利息收入
USD 23.5M
贷款资金
USD 1.3B
市值
USD 23.88B
净收入
USD 199.5M
营业费用
USD 936.6M
营业利润
USD 255.3M
普通股股本
USD 385.9M
PE价格收益
24.73
税前利润
USD 340.7M
销售收入
USD 1.19B
销售和管理费用
USD 349.7M
股票
USD 693.6M
贸易债权人
USD 1.94B
应收帐款人
USD 1.09B


税前利润 更改 日
Abbott USD 2.39B 27M 2026-03
Align Technology USD 148.89M 27.71M 2026-03
AtriCure USD 2.36M 2.45M 2025-12
Avanos Medical USD -1.2M 74.7M 2025-09
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Inogen USD -6.06M 467K 2024-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
J&J USD 7.82B 2.86B 2026-03
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Solventum Corp USD 511M 149M 2025-09
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
West Pharmaceutical Services USD 161.5M 8.6M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12